@MyelomaTeacher - Cindy Chmielewski (@myelomateacher) 's Twitter Profile
@MyelomaTeacher - Cindy Chmielewski

@myelomateacher

Retired Teacher- Dx with Myeloma 2008- Patient Research Advocate-Curriculum Director @HealthTreeU- @ASH_Hematology & @TheEBMT Speaker-IRB Member, #MMSM

ID: 32530883

linkhttp://facebook.com/myelomateacher calendar_today17-04-2009 19:20:58

47,47K Tweet

9,9K Followers

1,1K Following

Manni Mohyuddin (@mannimd1) 's Twitter Profile Photo

Long term follow up of elranatamab Phase 2 trial n=123 97% triple ref, 42% penta ref Median PFS=17 mo Median OS=24 mo Many still in response at latest follow-up onlinelibrary.wiley.com/doi/10.1002/he… (Goodbye ide-cel 😂) #mmsm

Long term follow up of elranatamab Phase 2 trial

n=123
97% triple ref, 42% penta ref
Median PFS=17 mo
Median OS=24 mo
Many still in response at latest follow-up

onlinelibrary.wiley.com/doi/10.1002/he…

(Goodbye ide-cel 😂)

#mmsm
Multiple Myeloma RF (@themmrf) 's Twitter Profile Photo

Today, we announced a new paper on our CoMMpass℠ study with our partners, Winship Cancer Institute of Emory University & TGen, which defines distinct subtypes and identifies high-risk genetic markers of #myeloma. Read the announcement here: ow.ly/HFnV50T1gwq

Journal of Clinical Oncology (@jco_asco) 's Twitter Profile Photo

📢Calling all oncology researchers! We’re accepting submissions for JCO Oncology Advances. Share impactful cancer research with a global community and contribute to advancing clinical oncology. Submit your work ➡️ brnw.ch/21wM6Ts #JCO #OncologyResearch #OpenAccess

Hamza Hashmi (@hhashmi87) 's Twitter Profile Photo

Hot off Press: Safety and Efficacy of #CART in #RRMM w sec #AL #Amyloidosis led by resident Cleveland Clinic ➡️Responses were rapid and deep ➡️No excessive or ⬆️Gr CRS ➡️Presence of amyloid should not be🛑🚧 CART pubmed.ncbi.nlm.nih.gov/39189919/ #mmsm #MedTwitter #UnmetNeed eJHaem Journal

Hot off Press: Safety and Efficacy of #CART in #RRMM w sec #AL #Amyloidosis led by resident <a href="/ClevelandClinic/">Cleveland Clinic</a> 
➡️Responses were rapid and deep
➡️No excessive or ⬆️Gr CRS
➡️Presence of amyloid should not be🛑🚧 CART
pubmed.ncbi.nlm.nih.gov/39189919/
#mmsm #MedTwitter #UnmetNeed <a href="/e_JHaem/">eJHaem Journal</a>
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

For ASH members. Im supporting Mikkael A. Sekeres MD, MS for ASH Secretary. He’s a leader in the field. A champion of changes to ABIM MOC. Please vote and support at: vote.escvote.com/ash

For <a href="/ASH_hematology/">ASH</a> members. Im supporting <a href="/MikkaelSekeres/">Mikkael A. Sekeres MD, MS</a> for ASH Secretary. 

He’s a leader in the field. A champion of changes to ABIM MOC. Please vote and support at: vote.escvote.com/ash
Andrew Yee, MD (@andrew02114) 's Twitter Profile Photo

Mass spectrometry is one of the most sensitive ways for detecting monoclonal protein in the peripheral blood. Similar to how there are different ways of detecting MRD in bone marrow (next generation sequencing or flow cytometry), there are different types of mass spec platforms

Mass spectrometry is one of the most sensitive ways for detecting monoclonal protein in the peripheral blood.  Similar to how there are different ways of detecting MRD in bone marrow (next generation sequencing or flow cytometry), there are different types of mass spec platforms
Bilal Abid, MD, MS (@bilalabidmd) 's Twitter Profile Photo

🚨Talk of the day: “Early vs late CAR-T in Myeloma.” No consensus reached but both sides up a notch w life qoutes, sports & music references! “Just bc you can do something doesn’t mean you should do it” Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Krina Patel MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center #SOHO2024 #SOHO24

🚨Talk of the day: “Early vs late CAR-T in Myeloma.” No consensus reached but both sides up a notch w life qoutes, sports &amp; music references!  “Just bc you can do something doesn’t mean you should do it” <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a>  <a href="/DrKrinaPatel/">Krina Patel</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> #SOHO2024  #SOHO24
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Starting next year, there will be a $2000 maximum out of pocket limit for what seniors pay for all their Part D medications. This is a MASSIVE relief. Especially for patients with cancer.

Starting next year, there will be a $2000 maximum out of pocket limit for what seniors pay for all their Part D medications. 

This is a MASSIVE relief. 
Especially for patients with cancer.
Amtrak Northeast (@amtraknecalerts) 's Twitter Profile Photo

SERVICE ALERT: As of 9:46 pm ET, Trains traveling between Philadelphia (PHL) and Trenton (TRE) may experience a delay due to police activity near the tracks. We will update as more information becomes available.